Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

E-therapeutics meets 'key milestone' in Galapagos collaboration

Fri, 02nd Jul 2021 13:47

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.
The AIM-traded firm said the milestone would result in a payment from Galapagos.

It explained that the objective of the collaboration between the company and Galapagos, which began in June 2020, was to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and other fibrotic indications.

Under the terms of the agreement, e-therapeutics was eligible to receive additional milestone payments through pre-clinical and clinical development, as well as commercial milestones.

"I am delighted with the progress of our collaboration with Galapagos following our recent update on 23 April," said chief executive officer Ali Mortazavi.

"We believe e-therapeutics' network biology approach will become an important component of small molecule drug discovery and we are implementing the same approach to our internal pipeline, using RNAi as the therapeutic modality of choice."

At 1328 BST, shares in e-therapeutics were down 0.44% at 22.4p.

Related Shares

More News
16 Jan 2024 10:34

IN BRIEF: e-Therapeutics shares rise on strong financial year

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says 2023 was

27 Dec 2023 10:27

IN BRIEF: e-Therapeutics shares to cease trading on OTCQX

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that its shares will cease to trade on the OTCQX Best Market i...

2 Nov 2023 14:34

EARNINGS AND TRADING: Kanabo inks CBD deal, Taseko boosts production

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

2 Nov 2023 14:32

E-Therapeutics enters collaboration with Arcturis Data

(Sharecast News) - E-Therapeutics announced a strategic collaboration with Arcturis Data on Thursday - a prominent UK data company known for its high-...

26 Oct 2023 18:12

EARNINGS: Riverstone Credit stays stable, Bloomsbury hails record half

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Wednesday and Thursday, and not separately rep...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.